AU2002330131A1 - Biopolymer and biopolymer-cell compositions for nerve tissue repair - Google Patents

Biopolymer and biopolymer-cell compositions for nerve tissue repair

Info

Publication number
AU2002330131A1
AU2002330131A1 AU2002330131A AU2002330131A AU2002330131A1 AU 2002330131 A1 AU2002330131 A1 AU 2002330131A1 AU 2002330131 A AU2002330131 A AU 2002330131A AU 2002330131 A AU2002330131 A AU 2002330131A AU 2002330131 A1 AU2002330131 A1 AU 2002330131A1
Authority
AU
Australia
Prior art keywords
biopolymer
tissue repair
nerve tissue
cell compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002330131A
Other versions
AU2002330131A8 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STREIT JACOB WOLFGANG
University of Florida
Original Assignee
STREIT JACOB WOLFGANG
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STREIT JACOB WOLFGANG, University of Florida filed Critical STREIT JACOB WOLFGANG
Publication of AU2002330131A1 publication Critical patent/AU2002330131A1/en
Publication of AU2002330131A8 publication Critical patent/AU2002330131A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
AU2002330131A 2001-09-28 2002-09-30 Biopolymer and biopolymer-cell compositions for nerve tissue repair Abandoned AU2002330131A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32519001P 2001-09-28 2001-09-28
US60/325,190 2001-09-28
PCT/US2002/030900 WO2003026489A2 (en) 2001-09-28 2002-09-30 Biopolymer and biopolymer-cell compositions for nerve tissue repair

Publications (2)

Publication Number Publication Date
AU2002330131A1 true AU2002330131A1 (en) 2003-04-07
AU2002330131A8 AU2002330131A8 (en) 2003-04-07

Family

ID=23266822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002330131A Abandoned AU2002330131A1 (en) 2001-09-28 2002-09-30 Biopolymer and biopolymer-cell compositions for nerve tissue repair

Country Status (2)

Country Link
AU (1) AU2002330131A1 (en)
WO (1) WO2003026489A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1874919B1 (en) 2005-04-21 2010-06-09 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
US20090311323A1 (en) * 2005-04-28 2009-12-17 Joaquin Cortiella Autologous somatic cells from peripheral blood and uses thereof
CN102743792B (en) 2005-06-21 2014-09-24 夏尔再生医学公司 Methods and compositions for enhancing vascular access
WO2008121331A1 (en) * 2007-03-30 2008-10-09 Pervasis Therapeutics, Inc. Materials and methods for treating nerve damage and promoting nerve repair and regeneration
WO2008157324A2 (en) * 2007-06-13 2008-12-24 Fmc Corporation Peptide linked cell matrix materials for stem cells and methods of using the same
ES2661762T3 (en) 2007-10-10 2018-04-03 Wake Forest University Health Sciences Devices to treat spinal cord tissue
EP2801377B1 (en) 2011-03-04 2019-08-07 The Regents of The University of California Hydrogel comprising cells for local release of growth factors to mediate motor recovery after stroke
KR101920277B1 (en) * 2011-06-03 2018-11-20 메소블라스트, 아이엔씨. Method of treating the effects of stroke
CA2870052A1 (en) * 2012-04-12 2013-10-17 Wake Forest University Health Sciences Design of a conduit for peripheral nerve replacement
WO2014066724A1 (en) 2012-10-26 2014-05-01 Wake Forest University Health Sciences Novel nanofiber-based graft for heart valve replacement and methods of using the same
US11027047B2 (en) 2015-03-31 2021-06-08 The University Of North Carolina At Chapel Hill Delivery vehicles for stem cells and uses thereof
GB2539006A (en) * 2015-06-03 2016-12-07 Ewos Innovation As Functional feed
CN107715178B (en) * 2017-11-09 2020-10-09 李瑞锋 Multilayer high-strength artificial dura mater containing cell factors and preparation method thereof
CN115531613B (en) * 2022-10-20 2023-11-17 武汉轻工大学 Nerve graft conduit filled with porous stent material, preparation method and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
US20030027760A1 (en) * 1993-12-23 2003-02-06 Gluckman Peter David Composition and methods to improve neural outcome
EP1301197A2 (en) * 2000-07-21 2003-04-16 The Board Of Regents, The University Of Texas System Device providing regulated growth factor delivery for the regeneration of peripheral nerves

Also Published As

Publication number Publication date
AU2002330131A8 (en) 2003-04-07
WO2003026489A2 (en) 2003-04-03
WO2003026489A3 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
AU2002351201A1 (en) Tissue repair
AU2003303513A1 (en) Tissue reactive compounds and compositions and uses thereof
AU2002210529A1 (en) Shear gel compositions
AU2003276014A1 (en) Bone growth compositions and methods
AU2003267644A1 (en) Dental compositions and methods
AU2002330131A1 (en) Biopolymer and biopolymer-cell compositions for nerve tissue repair
AU2003275268A1 (en) Hemostatic compositions and methods
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002365093A1 (en) Therapeutic compositions
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AUPR600601A0 (en) Therapeutic compositions
AU2002353078A1 (en) Tissue graft compositions and methods for producing same
AU2002337943A1 (en) Novel compositions and methods for cancer
AUPR446801A0 (en) Novel compositions and uses therefor
AU2003263962A1 (en) Tissue compositions and methods for producing same
AU2002321681A1 (en) Compositions and methods for the repair and construction of bone and other tissue
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2001288585A1 (en) Methods and compositions for tissue augmentation
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002255693A1 (en) Methods and compositions for crosslinking tissue
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase